Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Surgery|March 4, 2015
Predictors of surgical complications: A systematic reviewAnnelies Visser, Bart Geboers, Dirk J Gouma, et al.Chinese Clinical Oncology|December 24, 2019
Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?Bart Geboers, Alette H Ruarus, Sanne Nieuwenhuizen, et al.Nederlands Tijdschrift Voor Geneeskunde|December 2, 2021
[Irreversible electroporation: local tumor ablation with systemic immune effect]Bart Geboers, Florentine E F Timmer, Petrousjka M van den Tol, et al.BJU International|December 10, 2022
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancerMatthijs J Scheltema, Bart Geboers, Alexandar Blazevski, et al.Journal of Medical Imaging and Radiation Oncology|May 15, 2023
Transcatheter CT arteriography-guided irreversible electroporation of locally advanced pancreatic adenocarcinoma: A pictorial essayBart Geboers, Susan van der Lei, Louiza Te Kloppenborg, et al.BMC Urology|March 3, 2022
Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomesAlexandar Blazevski, William Gondoputro, Matthijs J Scheltema, et al.Techniques in Vascular and Interventional Radiology|June 28, 2020
Irreversible Electroporation for Locally Advanced Pancreatic CancerFlorentine E F Timmer, Bart Geboers, Alette H Ruarus, et al.Cancers|April 3, 2021
Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic ReviewFlorentine E F Timmer, Bart Geboers, Sanne Nieuwenhuizen, et al.BMC Urology|April 28, 2023
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancerPaul Doan, Athos Katelaris, Matthijs J Scheltema, et al.BJU International|January 3, 2023
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancerBart Geboers, Matthijs J Scheltema, Alexandar Blazevski, et al.Pageof 5